Physician profile
John G Mchenry
NPI 1770659104
$483.40
in general payments reported to CMS, 2019-2025
9 companies · $15.99 in 2025
The $15.99 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $265 · 2023: $34.90 · 2025: $15.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $175.08 | 2021-2025 | Tepezza |
| Innovation Technologies INC | $123.01 | 2021 | |
| Novartis Pharmaceuticals Corporation | $51.09 | 2022-2023 | |
| Lilly USA, LLC | $30.35 | 2022-2023 | Emgality, Reyvow |
| Hikma Pharmaceuticals USA | $30.34 | 2022 | |
| Mallinckrodt Hospital Products INC. | $28.55 | 2022 | |
| Thea Pharma INC. | $16.89 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.25 | 2022 | |
| Horizon Therapeutics Plc | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mchenry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.